about
Mechanistic target of rapamycin kinaseCaveolin 3Actinin alpha 2Alpha kinase 3Solute carrier family 8 member A1Sarcoglycan betaSarcoglycan, beta (43kDa dystrophin-associated glycoprotein)Heterogeneous nuclear ribonucleoprotein ULeucine rich repeat containing 10Actinin alpha 2Autophagy related 7Alpha-protein kinase 3Hepatocyte growth factor receptorEndoribonuclease DicerHeterogeneous nuclear ribonucleoprotein UHistone deacetylase 2Leucine rich repeat containing 10Solute carrier family 8 (sodium/calcium exchanger), member 1SPEG complex locusSarcoglycan, beta (dystrophin-associated glycoprotein)Xin actin-binding repeat-containing protein 1Caveolin 3Mechanistic target of rapamycin kinaseMechanistic target of rapamycin kinaseActinin alpha 2Leucine-rich repeat-containing protein 10-likeAlpha-kinase 3LanB1 Dmel_CG7123Collagen type IV alpha 1 Dmel_CG4145Scalloped Dmel_CG8544Caveolin 3Caveolin 3Leucine rich repeat containing 10Sarcoglycan beta
P682
Q14876092-6F478917-B8E8-407C-978D-04637A25F37FQ14901728-A59109E8-31EC-41D7-8CA2-25406BE8C0BFQ21096407-76514C5F-AEA3-4189-802C-533488000E9FQ21109400-3AF197C9-910B-49F6-9C3B-EFA5E0C036F0Q21119536-9B9018CD-F25E-45A6-BF0C-95EA29D5C54CQ21121398-732001A7-093E-4087-B78C-6315D8C750EDQ21137164-BEE551F9-76D1-4CB2-8F1F-A15BC62156E8Q21172295-90593D22-02F2-41B2-B02C-8ED4015AA8A2Q21207676-0F620635-C3E7-4651-B6EC-A7BBB63AC0EDQ21207676-41CD00CB-B9B5-4621-9662-C78567ADF469Q21493830-75632FDD-44BE-4D72-9363-1B54C43B037BQ21494884-F9BBC20B-1809-46B7-8CE4-EBE3ED24CB5FQ21498961-BE7CA468-A4C8-4DBE-BF49-CCC7B4AAA8F8Q21498961-F7588064-FBE5-4811-8F29-A43051959D1BQ21981691-B95F3DE5-0A79-4F13-BF2D-EB4672777A99Q21983162-D8F0E92C-8ECB-4948-9CC0-54E33D0DE8F9Q21984497-CD6B6E7E-A2F1-4AAA-BCA4-B02BC2F6732CQ21984934-3E28D3D2-5B54-4BC4-8DDE-03E89A0EFFD4Q21987621-74AD9684-817B-4FE7-B71E-1D94DEBEECC7Q21987621-EFE7018D-646E-4EDA-B041-DF98D3CBFFC7Q21988330-1E062428-2871-4395-9DD3-A06BF2BBA016Q21989531-27F6F590-1851-4E39-8373-934495E2004BQ21990124-292E27B0-666D-4633-AFF6-ED2D340B785DQ21990798-0B7F3DF4-99E9-469B-BB69-7AE8ADC30968Q28559503-C113CE13-9A2D-4814-8329-DBB3C43D1296Q285613-7B250B9C-7140-4204-890A-D503D2A00892Q28562648-25662C37-A598-4A14-A17A-617F0DF9C27BQ29516617-D246A0E5-5C7B-4303-8047-E4F16FE2FEE9Q29518758-17A98677-4BDF-47ED-8BC3-7459FC276704Q29526197-CA30AA72-016D-4FD1-9705-B490A2E4653DQ29808973-82122977-8437-4665-8D0B-06FC97394FC2Q29817579-95320653-5222-440B-B7AD-3F2990BFD8DCQ29820585-22CA3AAE-1A47-4DC1-9212-ACBD319BB321Q5055040-ACAD459D-8806-4050-9DF5-47428B058482Q55198395-E1E8062C-69CE-468C-BEE4-1710D68D96A9Q55200101-2B4E29CE-8AFD-4879-9165-EDD647DB0131Q55204424-3DD6EE83-6E08-4BE9-9183-4DF3F822A1A0
P682
description
The process whose specific out ...... formation to the mature state.
@en
biologisch proces
@nl
name
cardiac muscle cell development
@en
utviking av hjartemuskelcelle
@nn
type
label
cardiac muscle cell development
@en
utviking av hjartemuskelcelle
@nn
altLabel
GO:0055013
@en
cardiomyocyte cell development
@en
heart muscle cell development
@en
utvikling av kardiomyocytt
@nn
prefLabel
cardiac muscle cell development
@en
utviking av hjartemuskelcelle
@nn
P2888
P686
GO:0055013